AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
289 hedge funds and large institutions have $2.91B invested in Amedisys in 2024 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 105 increasing their positions, 82 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $3.04B → $2.91B (-$124M)
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
80% less call options, than puts
Call options by funds: $72M | Put options by funds: $360M
Holders
289
Holding in Top 10
11
Calls
$72M
Puts
$360M
Top Buyers
| 1 | +$64.5M | |
| 2 | +$63.3M | |
| 3 | +$50.2M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$48.6M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$47.7M |
Top Sellers
| 1 | -$84.3M | |
| 2 | -$63.6M | |
| 3 | -$52M | |
| 4 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
-$32.8M |
| 5 |
Amundi
Paris,
France
|
-$27.2M |